Source:http://linkedlifedata.com/resource/pubmed/id/10535689
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-11-4
|
pubmed:abstractText |
Oxygen free radicals have been shown to interfere with pancreatic islet beta cell function and integrity, and have been implicated in autoimmune type 1 diabetes. We hypothesized that the spontaneous autoimmune type 1 diabetes of the BB rat would be prevented by in vivo administration of a free-radical spin trap, alpha-phenyl-N-tert-butylnitrone (PBN). Twenty-eight diabetes-prone (BBdp) and 13 non-diabetes-prone (BBn) rats received PBN (10 mg/kg) subcutaneously twice daily, and 27 BBdp and 12 BBn rats received saline as controls. Rats were treated from age 47 +/- 6 days until diabetes onset or age 118 +/- 7 days. PBN caused no growth, biochemical, or hematological side effects. Sixteen control BBdp rats became diabetic (BBd, mean age 77 +/- 6 days) and six demonstrated impaired glucose tolerance (IGT rats). The incidence of diabetes and IGT was not different in PBN-treated BBdp rats. Saline-treated rats showed no differences in pancreatic malondialdehyde (MDA) contents of BBd, IGT rats, and the BBdp that did not develop diabetes, versus BBn rats (2.38 +/- 0.35 nmoL/g). Among rats receiving PBN, BBn had lower pancreatic MDA than BBd and IGT rats (1.38 +/- 0.15 vs. 1.88 +/- 0.15 and 2.02 +/- 0.24 nmoL/g, p < 0.05), but not than BBdp rats (1.78 +/- 0.12 nmoL/g, ns). BBn rats receiving PBN also had lower pancreatic MDA than the saline controls (p < 0.05). Thus, PBN is remarkably nontoxic and is able to decrease MDA in the absence of the autoimmune process, but does not prevent diabetes. A combination of PBN with other complementary antioxidant agents may hold better promise for disease prevention.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic N-Oxides,
http://linkedlifedata.com/resource/pubmed/chemical/Malondialdehyde,
http://linkedlifedata.com/resource/pubmed/chemical/Nitrogen Oxides,
http://linkedlifedata.com/resource/pubmed/chemical/Spin Labels,
http://linkedlifedata.com/resource/pubmed/chemical/phenyl-N-tert-butylnitrone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-4212
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
77
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
166-74
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10535689-Animals,
pubmed-meshheading:10535689-Cyclic N-Oxides,
pubmed-meshheading:10535689-Diabetes Mellitus, Type 1,
pubmed-meshheading:10535689-Female,
pubmed-meshheading:10535689-Glucose Tolerance Test,
pubmed-meshheading:10535689-Lipid Peroxidation,
pubmed-meshheading:10535689-Male,
pubmed-meshheading:10535689-Malondialdehyde,
pubmed-meshheading:10535689-Nitrogen Oxides,
pubmed-meshheading:10535689-Pancreas,
pubmed-meshheading:10535689-Rats,
pubmed-meshheading:10535689-Rats, Inbred BB,
pubmed-meshheading:10535689-Spin Labels
|
pubmed:year |
1999
|
pubmed:articleTitle |
Effect of alpha-phenyl-N-tert-butylnitrone on diabetes and lipid peroxidation in BB rats.
|
pubmed:affiliation |
McGill Nutrition and Food Science Centre, Royal Victoria Hospital, Montréal, QC, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|